"Next, this lady." Chen Qiuyu pointed to a European lady with blond hair and blue eyes.
"Hello, Ms. Chen, I am a reporter from The Times. The price of your company's 'probiotics' is so high, which is unfair to most cancer patients. What do you think of this problem?"
"According to our understanding, the cost of treating terminal diseases including cancer has remained high around the world. For example, the overall cost of liver transplant surgery to treat liver cancer in China, including early treatment and late anti-rejection, will not The cost is less than 1 million yuan, and the survival time of patients who have undergone liver transplantation is no more than 5 years.
If two treatment methods, the use of 'probiotics' to treat liver cancer and surgical liver transplantation to treat liver cancer, are roughly the same, which treatment method do you think the patient will use?
The total cost of the same surgery in developed countries around the world is more than $500,000. If these two treatment methods exist, do you think they will resort to liver transplant surgery in order to save $500,000?
This is one of the bases on which we set the price of 'probiotics', that is, the cost of treatment for the same disease is basically the same as today.
Second, the company determines the sales price based on the production cost of 'prebiotics'. Journalists here all have a certain understanding of the factors that determine prices, and research costs will account for a certain proportion of them.
Third, we deeply feel that the company's production capacity cannot meet the needs of the vast number of cancer patients in China and even the world. In order to increase the company's production capacity as soon as possible, we also need to raise a large amount of funds, continue to expand production capacity to meet the growing needs of cancer patients, and make the greatest efforts to eliminate cancer worldwide.
Cancer patients who have been treated with probiotics in advance are the biggest beneficiaries. While the company meets their needs, they also contribute to the company's development and growth.
The reporters in the venue were speechless for a while, and there was such a domineering thing. You need to continuously expand production capacity, and patients must continue to provide you with funds. If you don't provide funds, it won't work. It is really worse than a robber.
Reporters secretly compared the actions of some monopoly industries with Star Pharmaceuticals. Really, it is impossible for other industries to have such irreplaceable and determined demands.
For example, if there is no Microsoft, I can use software from other companies. Even if there are no other software companies, I can always do without a computer.
But cancer patients really can't survive without "probiotics". This is why "Star Pharmaceuticals" dares to blatantly blackmail the world, and the blackmailed can only accept it willingly.
Next, a Japanese reporter asked: "Ms. Chen, I am Xiaogu Erlang, a reporter from the Japanese Daily News. Do you know that the number of cancer patients in the world accounts for about 1.651% of the global population, which means that about every 59 people have cancer. One person suffers from cancer, and there are more than 6 billion people in the world, and there are more than 100 million cancer patients.
Moreover, the survival period after cancer detection is very short. In order to save the lives of thousands of cancer patients, will your company consider making the manufacturing technology and process of 'probiotics' available to the public, so that more capable people can Companies are involved in the production of 'prebiotics' to best meet the needs of cancer patients around the world. "
The reporters in the audience all looked at this Japanese reporter as if they were a fool. It's not scary to be an idiot alone, but the scary thing is the idiot who became a reporter.
The venue was noisy, and voices rebuking the Japanese reporter filled the entire venue. The reporters present generally believed that such questions that were grandiose, high-sounding, and contained evil intentions could only be raised by reporters from a rogue country like Japan.
However, this Japanese reporter was very proud. He felt that this question not only made him steal the limelight, but also dug a big hole for Xingkong Pharmaceutical, causing Xingkong Pharmaceutical to sink in the moral whirlpool.
"Reporter from Japan, right? I am moved by your sentiment of praying for the people of the world. I think all entrepreneurs and managers in Japan will also be moved by your noble character.
I hope you can return to China and call on Japan's large companies, such as Mitsubishi Heavy Industries, Mitsui Heavy Industries, Sony, etc., to let them disclose all their proprietary technologies and production processes to the world, so that the world's scientific and technological development can advance with each passing day, and manufacturing Produce more and better products to meet the needs of people around the world and benefit people around the world.
Our company will also actively respond to the initiative of Japanese companies and companies from all over the world to disclose our technology and production processes. You can rest assured that our company will never break its promise. "
Ms. Chen Qiuyu's words made Xiao Quan Erlang turn pale.
Ms. Chen Qiuyu continued: "Xingkong Pharmaceutical is just a small business with fixed assets of only US$10 million.
But our biggest advantage is that we have the most dedicated scientific researchers. In order to better utilize their talents and talents, we can develop more and better drugs to relieve the pain of various patients around the world.
Our company will provide them with better and advanced test conditions, which requires us to increase investment in scientific research.
I can tell reporters in advance that another of our company's special drugs for kidney disease, "Shenkang", is about to enter the clinical trial stage. It can unblock renal tubular lumen and repair damaged tubular necrosis or damage. Injuries caused by rupture of the renal tubule wall and other causes can allow glomerular cells to quickly restore their functions.
'Shenkang', a high-tech biological gene therapy drug, can make patients with renal failure and renal necrosis fully recover within eight hours after injection. It avoids the pain of kidney transplantation for patients with severe kidney disease and the short survival period after kidney transplantation, allowing patients to completely have a healthy kidney. As long as patients with kidney disease have no other serious complications, the cure rate of 'Shenkang' is 100%. "
The reporters in the audience were excited again. The experts from the World Health Organization and the China Food and Drug Administration sitting in the front row could not sit still and began to whisper to each other to exchange the information they had obtained from the news released by Chen Qiuyu. .
One of the doctors from a famous German medical research institution stood up and said: "Ms. Chen, today is not April Fool's Day. I believe that Ms. Chen's news release was approved by Chairman Chen Ning, but I still have to ask, this Is it true? This is unbelievable."
Chen Qiuyu said to the German expert: "Dr. Felix, the application report and attachments for the Phase 1 clinical trial of 'Shenkang' will be submitted to the China Food and Drug Administration in the near future.
Our company sincerely invites Dr. Felix and the experts from the World Health Organization and other members of the evaluation team present here to participate in the clinical trial of the biogenetic drug "Shenkang" and provide supervision and evaluation. After saying that, she nodded to Dr. Felix, indicating that he could sit down.